The p38 protein regulates a wide variety of cellular functions and is related to diseases such as chronic inflammation, immunological disorders, or cancer. To date, it has been difficult to find p38 inhibitors for use in clinical practice because the candidates produce toxic effects that preclude their administration at adequate therapeutic doses.
Click here for original story, Development of new p38 protein inhibitors with therapeutic potential for some heart diseases
Source: Phys.org